氨基酸代谢重编程:为T细胞抗瘤免疫提供了新的了解
Yue Zheng1,2, Yiran Yao1,2, Tongxin Ge1,2
1Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 20025, P. R. China.
Journal of experimental & clinical cancer research : CR
|November 4, 2023
概括
氨基酸代谢促进癌症生长,并影响T细胞免疫力. 针对这些代谢途径提供了新的策略来增强抗瘤疗法并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 氨基酸代谢对于瘤的开始,生长和生存至关重要.
- 氨基酸的代谢重编程是癌症的标志.
- 新出现的证据强调了氨基酸代谢在调节抗瘤免疫反应中的作用.
研究的目的:
- 审查最近关于氨基酸代谢和T细胞免疫之间的交叉声的发现.
- 描述针对氨基酸代谢途径的潜在治疗策略.
- 讨论新的方法,将代谢干预与免疫治疗结合起来.
主要方法:
- 关于氨基酸代谢和癌症免疫力的最新研究的文献综述.
- 分析瘤细胞改变氨基酸水平以影响T细胞的机制.
- 针对氨基酸代谢的治疗干预措施的探索.
主要成果:
- 氨基酸代谢显著影响T细胞功能和抗瘤免疫力.
- 瘤细胞利用氨基酸代谢来逃避免疫监测.
- 代谢干预可以调节瘤微环境和T细胞反应.
结论:
- 准氨基酸代谢是癌症治疗的一个有希望的途径.
- 将代谢策略与免疫疗法结合起来,可以克服治疗耐药性.
- 对氨基酸代谢途径的进一步研究可能会导致癌症的新型组合疗法.
相关概念视频
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
T Cell Activation and Clonal Selection
753
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
753
Cell-mediated Immune Responses
68.6K
Overview
68.6K
Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


